Save time and get answers to complex questions with AI chat
When is tenofovir alafenamide patent expiring?Is januvia still on the market?When is the expected fda decision date for apotex's ruxolitinib resubmission?Are there specific stretches to avoid while on lipitor?Xiaflex market launch year?
See the DrugPatentWatch profile for Drizalma
Drizalma Sprinkle's approval date in 2019 is not directly available in the provided information. However, Drizalma is an oral liquid formulation of diclofenac used to treat pain in patients 23 months of age and older. It was developed by Acura Pharmaceuticals. [1]
Drizalma Sprinkle is indicated for the relief of mild to moderate pain in patients 23 months of age and older. It is an oral liquid formulation of diclofenac, a nonsteroidal anti-inflammatory drug (NSAID). [1]
Drizalma Sprinkle was developed by Acura Pharmaceuticals. [1]
The active ingredient in Drizalma Sprinkle is diclofenac. [1]
Drizalma Sprinkle is an NSAID that works by inhibiting cyclooxygenase (COX) enzymes, which are involved in the synthesis of prostaglandins. Prostaglandins are mediators of inflammation, pain, and fever. By reducing prostaglandin production, diclofenac helps to alleviate pain and inflammation. [1]
Other Questions About Drizalma :